Vol. 23 (1) 2002 Neuro endocrinology letters

Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.

OBJECTIVES: The secretion of prolactin (PRL), which is a growth factor for prostate cancer cell proliferation, has been proven to present profound alterations in advanced prostate cancer patients, consisting of abnormally elevated baseline levels and paradoxical response to L-dopa. Moreover, the efficacy of standard therapies for prosta.....